A20 has been found to have antiapoptotic function in several cancer cells, its increased expression is associated with tumorigenesis, and it is involved in drug resistance in many cancers, such as glioblastomas, breast cancer, hepatocellular carcinoma, and nasopharyngeal carcinoma (NPC) [16–21]. The gene discussed is TNFAIP3; the disease is breast carcinoma.